Ruichu Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 13

Ruichu General Information

Description

Developer of anti-ageing therapeutics designed to prevent, treat and reverse age-related diseases. The company utilises targeted clearance of senescent cells and partial reprogramming to develop inhalation powders, ophthalmic ointments, Bcl-xL inhibitors, anti-ageing therapeutics, degenerative disease treatments and age-related disease drugs, providing the healthcare sector with solutions to enhance human healthspan.

Contact Information

Website
rejutec.com.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4th Floor, Building 6
  • Number 699-18 Xuanwu Avenue
  • Nanjing, Jiangsu 210000
  • China
+86 150
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 4th Floor, Building 6
  • Number 699-18 Xuanwu Avenue
  • Nanjing, Jiangsu 210000
  • China
+86 150

Ruichu Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ruichu Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 13-Oct-2026 Completed Generating Revenue
7. Later Stage VC (Series A) 21-Oct-2026 Completed Generating Revenue
6. Secondary Transaction - Private 28-Jul-2025 Completed Generating Revenue
5. Early Stage VC 01-Jul-2025 Completed Generating Revenue
4. Early Stage VC 07-Aug-2024 Completed Generating Revenue
3. Early Stage VC 11-Dec-2023 Completed Generating Revenue
2. Early Stage VC 18-Oct-2022 Completed Generating Revenue
1. Corporate 14-Oct-2021 Completed Generating Revenue
To view Ruichu’s complete valuation and funding history, request access »

Ruichu Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cathay Capital PE/Buyout Minority
Fosun Health Capital Corporate Venture Capital Minority
Huatai Zijin Investment Corporate Venture Capital Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
Nanjing Gaoke Company Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Ruichu FAQs

  • When was Ruichu founded?

    Ruichu was founded in 2021.

  • Where is Ruichu headquartered?

    Ruichu is headquartered in Nanjing, China.

  • What industry is Ruichu in?

    Ruichu’s primary industry is Drug Discovery.

  • Is Ruichu a private or public company?

    Ruichu is a Private company.

  • What is Ruichu’s current revenue?

    The current revenue for Ruichu is .

  • How much funding has Ruichu raised over time?

    Ruichu has raised $14M.

  • Who are Ruichu’s investors?

    Cathay Capital, Fosun Health Capital, Huatai Zijin Investment, Shenzhen Yifeng Investment Management Enterprise, and Nanjing Gaoke Company are 5 of 13 investors who have invested in Ruichu.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process